Market Overview and Growth Outlook
The bioresorbable polymers market reached US$560 million in 2025 and is forecast to achieve US$1.1 billion by 2031. This expansion reflects the increasing integration of biodegradable, biocompatible polymers into medical devices that provide temporary support within the body.
The bioresorbable polymers market is expected to grow at a CAGR of 12% during 2025–2031.
Orthopedic applications remain an important demand foundation. Bioresorbable polymers are used in fixation devices, including screws, pins, and plates, where temporary mechanical support is required.
Unlike permanent implants, bioresorbable materials gradually degrade and are absorbed by the body. This property can reduce secondary procedures for device removal and support improved patient recovery outcomes.
The industry's growth analysis therefore extends beyond material consumption to the changing requirements of orthopedic and surgical technologies.
Understanding bioresorbable polymers market size requires examining the medical applications that support material demand. Orthopedic fixation remains the largest application area, while controlled drug delivery is expanding rapidly. Both applications depend on polymers with suitable biocompatibility and degradation characteristics. The market forecast reflects increasing use of these materials in medical technologies designed for temporary structural support and therapeutic delivery.
Request a free sample report: https://www.stratviewresearch.com/Request-Sample/bioresorbable-polymers-market#form
Market Segmentation Analysis
By Type, the market includes Polylactic acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), and Polycaprolactone (PCL).
Polylactic acid (PLA) is the largest type segment. Its established use in orthopedic fixation products and sutures reflects favorable mechanical properties, cost-effectiveness, and a long history of medical applications.
Polycaprolactone (PCL) is the fastest-growing type segment. Its slower degradation and mechanical strength make it suitable for tissue engineering, regenerative medicine, and long-term implants.
By Application, the bioresorbable polymers market is divided into Orthopedic Devices and Drug Delivery.
Orthopedic Devices constitute the dominant application category. Fixation products manufactured using bioresorbable polymers support the healing process while reducing the need for additional implant-removal procedures.
Drug Delivery is the fastest-growing application segment. Controlled release characteristics, improved bioavailability, and the elimination of device removal requirements support its increasing adoption.
Regional Market Insights
Asia-Pacific
Asia-Pacific is the fastest-growing market for bioresorbable polymers. Increasing expenditure on healthcare infrastructure and wider adoption of advanced medical devices are important regional growth drivers.
Expanding medical tourism also supports market development. Investment in modern hospitals and innovative treatment approaches across China, India, and Southeast Asian countries is encouraging the use of bioresorbable medical technologies.
Emerging Trends Shaping the Bioresorbable Polymers Market
The increasing use of temporary orthopedic implants represents a central industry trend. Devices manufactured from bioresorbable materials provide structural support during healing and gradually degrade afterward.
Materials innovation is another important development. Research into mechanical strength, biocompatibility, and controlled degradation supports the continued refinement of medical-grade polymers.
The market is also experiencing wider application of these materials in regenerative medicine. Tissue repair and bone-healing systems are benefiting from the properties of polymers such as Polycaprolactone (PCL).
Together, these developments strengthen the industry outlook for advanced medical materials.
Key Growth Drivers of the Market
- Orthopedic fixation requirements: Fracture treatment and temporary bone support applications create demand for bioresorbable screws, plates, and pins.
- Reduced secondary surgeries: Materials that degrade after completing their intended function can eliminate certain implant-removal procedures, supporting patient recovery.
- Increasing medical device innovation: Development of advanced implants encourages the use of materials with controlled degradation and suitable mechanical properties.
- Expanding regenerative medicine: Tissue engineering and bone-healing applications support demand for polymers capable of providing temporary structural functions.
- Growing healthcare investment: Modern hospital development and adoption of innovative treatments support wider use of bioresorbable devices, particularly in Asia-Pacific.
Competitive Landscape
The competitive landscape includes more than 80 market participants and is moderately fragmented. Pricing, service offerings, and regional presence are important competitive considerations.
Top Companies in the Market
- Corbion N.V.
- Evonik Industries AG
- DSM Biomedical
- Poly-Med Inc
- Ashland Global Holdings Inc.
- KLS Martin Grou
- Foster Corporation
- Zeus Industrial Products Inc.
- SEQENS SAS
- Reva Medical LLC
Conclusion and Strategic Outlook
The bioresorbable polymers market is expected to increase from US$560 million in 2025 to US$1.1 billion by 2031, growing at a CAGR of 12%.
Orthopedic fixation provides an established commercial foundation, while regenerative medicine and drug delivery expand the range of medical applications.
The market forecast indicates sustained development as biocompatibility, mechanical performance, and controlled degradation remain central material-selection criteria.
FAQs – Bioresorbable Polymers Market
1. How large is the bioresorbable polymers market?
The global bioresorbable polymers market was valued at US$560 million in 2025. Its forecast value is US$1.1 billion by 2031.
2. At what rate is the industry expected to grow?
The bioresorbable polymers market is forecast to grow at a CAGR of 12% during 2025–2031. Orthopedic and therapeutic applications support the growth trajectory.
3. Why are orthopedic applications important to market growth?
Orthopedic Devices represent the dominant application segment. Bioresorbable fixation products provide temporary structural support and can reduce the need for implant-removal procedures.
4. Where is regional demand expanding fastest?
Asia-Pacific is the fastest-growing market. Healthcare infrastructure investment, medical tourism, and advanced medical device adoption are supporting demand.
5. What factors shape the industry's competitive and investment outlook?
Market participants compete on pricing, service offerings, and geographic presence. Future opportunities are linked to medical device development, polymer innovation, and expanding therapeutic applications.
